Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Bausch Health Companies Inc.    BHC   CA0717341071

BAUSCH HEALTH COMPANIES INC.

(BHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Bausch Health : To Participate at 2020 Bank of America Merrill Lynch Global Healthcare Conference

share with twitter share with LinkedIn share with facebook
04/30/2020 | 07:01am EDT

LAVAL, Quebec, April 30, 2020 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that  Joseph C. Papa, chairman and chief executive officer, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the virtual Bank of America Merrill Lynch Global Healthcare Conference on May 12, 2020, at 1:40 p.m. EDT.

A live webcast and audio archive of the events will be available on the Investor Relations page of the Bausch Health Companies Inc. web site at: http://ir.bauschhealth.com/events-and-presentations/2020.

About Bausch Health 
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Investor Contact:

Media Contact:

Arthur Shannon

Lainie Keller

arthur.shannon@bauschhealth.com 

lainie.keller@bauschhealth.com

(514) 856-3855

(908) 927-1198

(877) 281-6642 (toll free)


 

Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)

 

Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch-health-to-participate-at-2020-bank-of-america-merrill-lynch-global-healthcare-conference-301047818.html

SOURCE Bausch Health Companies Inc.

© Canada Newswire, source Canada Newswire English

share with twitter share with LinkedIn share with facebook
Latest news on BAUSCH HEALTH COMPANIES IN
07/08TSX edges higher as gold prices rise, virus concerns cap gains
RE
06/24BAUSCH HEALTH : Ortho dermatologics announces arazlo lotion, 0.045%, now availab..
AQ
06/24BAUSCH HEALTH COMPANIES INC : . - Ortho Dermatologics Launches ARAZLO Lotion, 0...
AQ
06/23BAUSCH HEALTH : Ortho Dermatologics Launches ARAZLO™ (tazarotene) Lotion, ..
AQ
06/18BAUSCH HEALTH : + LOMB ULTRA Silicone Hydrogel Contact Lenses Receive Approval i..
AQ
06/11BAUSCH HEALTH : Health Canada Issues Notice of Compliance for Bausch Health's DU..
AQ
06/09EXCLUSIVE : Chanel, Revlon, L'Oreal pivoting away from talc in some products
RE
06/09EXCLUSIVE : Chanel, Revlon, L'Oreal pivoting away from talc in some products
RE
06/05BAUSCH HEALTH : FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE Daily Dis..
AQ
05/28BAUSCH HEALTH : + Lomb Announces The European Launch Of LuxSmart And LuxGood Pre..
AQ
More news
Financials (USD)
Sales 2020 8 039 M - -
Net income 2020 -411 M - -
Net Debt 2020 22 174 M - -
P/E ratio 2020 -15,2x
Yield 2020 -
Capitalization 6 172 M 6 172 M -
EV / Sales 2019
EV / Sales 2020 3,53x
Nbr of Employees 21 700
Free-Float 99,4%
Chart BAUSCH HEALTH COMPANIES INC.
Duration : Period :
Bausch Health Companies Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAUSCH HEALTH COMPANIES IN
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 27,30 $
Last Close Price 17,40 $
Spread / Highest target 268%
Spread / Average Target 56,9%
Spread / Lowest Target -19,5%
EPS Revisions
Managers
NameTitle
Joseph C. Papa Chairman & Chief Executive Officer
Paul S. Herendeen Chief Financial Officer & Executive Vice President
Tage Ramakrishna Chief Medical Officer, President-R&D
Robert N. Power Independent Director
David Robert Hale Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BAUSCH HEALTH COMPANIES INC.-41.81%6 176
JOHNSON & JOHNSON-0.45%382 569
ROCHE HOLDING AG7.29%304 280
PFIZER, INC.-10.13%195 586
MERCK & CO., INC.-14.95%195 239
NOVARTIS AG-10.58%192 304